Clinical Trials Directory

Trials / Terminated

TerminatedNCT01110070

ChonDux for Filling Full Thickness Cartilage Defects in the Femoral Condyle of the Knee

Pivotal Study in Europe for CE Mark

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Zimmer Biomet · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The use of ChonDux Cartilage Repair system for the treatment of single cartilage lesions in the femoral condyle of the knee. The primary outcome measure is degree of lesion fill at 6 months. Filling of the femoral chondral defect of the knee using ChonDux™ Cartilage System may give symptomatic relief of pain and help to restore knee function. Included in this study is pain relief using Visual Analog Scale (VAS), knee function using the International Knee Documentation Committee (IKDC) questionnaire and quality of life using the Short Form-36 (SF-36) survey.

Detailed description

Current treatment approaches for articular cartilage defects have been disappointing and clinical results have been variable. However, when using crosslinked hydrogel technologies, in vitro findings have shown chondrocyte growth and extra-cellular matrix (ECM) production supportive of cartilage production.

Conditions

Interventions

TypeNameDescription
DEVICEChonDuxComparison of ChonDux plus microfracture to microfracture only
DEVICEChonDuxsingle use device

Timeline

Start date
2010-07-01
Primary completion
2010-12-01
Completion
2012-12-01
First posted
2010-04-26
Last updated
2017-07-07

Locations

7 sites across 3 countries: Austria, Germany, Netherlands

Source: ClinicalTrials.gov record NCT01110070. Inclusion in this directory is not an endorsement.